DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient: A Case Report.

about

Twelve-week randomized study to compare the effect of vildagliptin vs. glibenclamide both added-on to metformin on endothelium function in patients with type 2 diabetes and hypertension.A Practical Approach to Hypertension Management in Diabetes

P2860

Q35997260-90CD72C8-DDFC-4AAA-ACBC-8AC0366D17FE Q42371757-52BA16FE-E1FE-4BB1-9199-CA5C9E03622F

P2860

DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient: A Case Report.

Item

http://www.wikidata.org/entity/Q35858226

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

DPP-4 Inhibitor Reduces Centra ...... ensive Patient: A Case Report.

@ast

DPP-4 Inhibitor Reduces Centra ...... ensive Patient: A Case Report.

@en

type

Item

label

DPP-4 Inhibitor Reduces Centra ...... ensive Patient: A Case Report.

@ast

DPP-4 Inhibitor Reduces Centra ...... ensive Patient: A Case Report.

@en

prefLabel

DPP-4 Inhibitor Reduces Centra ...... ensive Patient: A Case Report.

@ast

DPP-4 Inhibitor Reduces Centra ...... ensive Patient: A Case Report.

@en

P1476

DPP-4 Inhibitor Reduces Centra ...... ensive Patient: A Case Report.

@en

P2093

José Fernando Vilela-Martin

http://www.w3.org/2001/XMLSchema#string

Luciana Neves Cosenso-Martin

http://www.w3.org/2001/XMLSchema#string

Luiz Tadeu Giollo-Junior

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Low-fat versus low-carbohydrate weight reduction diets: effects on weight loss, insulin resistance, and cardiovascular risk: a randomized control trial.

Arterial stiffness and cardiovascular events: the Framingham Heart Study

The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.

Effects of resistance training on central blood pressure in obese young men

Augmentation index derived from peripheral arterial tonometry correlates with cardiovascular risk factors.

Vildagliptin improves endothelium-dependent vasodilatation in type 2 diabetes

Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques

P304

e1068

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1097/MD.0000000000001068

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26166078

http://www.w3.org/2001/XMLSchema#string

P932

4504643

http://www.w3.org/2001/XMLSchema#string

DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient: A Case Report.

about

P2860

P2860

DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient: A Case Report.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932